INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2021

Resveratrol supplementation improved cognitive performance, cerebrovascular function, and insulin sensitivity in postmenopausal women.

In a 24-month crossover trial, 125 postmenopausal women aged 45-85 years took 75 mg trans-resveratrol or placebo twice daily for 12 months, followed by the alternative treatment for 12 months. Compared to placebo, resveratrol resulted in a significant 33% improvement in overall cognitive performance (Cohen's d = 0.170, P = 0.005). Resveratrol also improved resting mean cerebral blood flow velocity (d = 0.275, P = 0.001), cerebrovascular responsiveness to hypercapnia (d = 0.307, P = 0.027) and cognitive stimuli (d = 0.259, P = 0.032), fasting insulin (d = 0.174, P = 0.025), and insulin resistance index (d = 0.102, P = 0.034). Women aged 65 and older showed a relative improvement in verbal memory compared to those younger than 65 years.

Study type
Randomized, double-blind, placebo-controlled crossover trial
Who was studied
125 postmenopausal women aged 45-85 years
What was measured
Cognition, cerebrovascular function in the middle cerebral artery, and cardio-metabolic markers

THE PAPER

Long-term effects of resveratrol on cognition, cerebrovascular function and cardio-metabolic markers in postmenopausal women: A 24-month randomised, double-blind, placebo-controlled, crossover study.

Thaung Zaw JJ, Howe PR, Wong RH. Clin Nutr, 2021.

PubMed 32900519 ↗DOI 10.1016/j.clnu.2020.08.025 ↗

Diabetes & blood sugarBrain & moodHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.